2026 Farm Bill Passes House with Hemp Ban Intact: What the $28B Industry Does Next

The House Has Spoken — and Hemp Companies Are Scrambling

On April 30, 2026, the U.S. House of Representatives voted 224-200 to pass the Farm, Food, and National Security Act of 2026. Buried within the sprawling agricultural legislation is a provision that could end the legal hemp-derived cannabinoid market as Americans know it: the intoxicating hemp product ban remains intact, and Congress has shown no appetite to delay it.

The ban, originally tucked into the Continuing Appropriations and Extensions Act signed by President Trump on November 12, 2025, narrows the federal definition of hemp and caps finished hemp-derived cannabinoid products at a razor-thin 0.4 milligrams of total THC per container. That threshold effectively eliminates the vast majority of delta-8, delta-9, THC-A, and other psychoactive hemp products currently sold in gas stations, dispensaries, and online shops across the country.

The clock is ticking. The ban takes effect on November 12, 2026, giving the industry roughly five months to adapt, pivot, or perish.

What the New THC Cap Actually Means

Before 2025, hemp was defined federally as cannabis containing less than 0.3 percent delta-9 THC on a dry-weight basis. That narrow definition created a massive loophole, and entrepreneurs pounced. By exploiting the distinction between delta-9 THC and other cannabinoids like delta-8, THC-A, and THC-O, hemp-derived products with significant psychoactive effects flooded the market.

The 2026 Farm Bill preserves the new compliance framework that replaces the old percentage-based test with a hard milligram cap. Under the updated rules, total THC now includes both delta-9 THC and THC-A, and the combined amount cannot exceed 0.4 milligrams per finished container. A typical hemp-derived gummy containing 10 milligrams of delta-9 THC would exceed the limit by twenty-five times.

For context, the 0.4-milligram cap is roughly equivalent to a single poppy seed's worth of THC — functionally zero in terms of psychoactive effect. Products that currently dominate the hemp market would become illegal overnight.

An Industry Worth $28 Billion Faces an Existential Threat

The numbers are staggering. The U.S. hemp-derived cannabinoid market supports approximately 328,000 jobs and generates an estimated $28 billion in annual revenue. Unlike the state-licensed cannabis industry, hemp products are sold in all 50 states without requiring dispensary licenses, often through convenience stores, smoke shops, and e-commerce platforms.

Industry advocacy groups have descended on Capitol Hill in force. The Hemp Industries Association, the U.S. Hemp Roundtable, and dozens of smaller trade organizations have argued that an outright ban will devastate rural economies where hemp farming has become a lifeline. They point to states like Kentucky, Tennessee, and Oregon, where hemp cultivation has replaced struggling tobacco and timber operations.

The counterargument from lawmakers, particularly Senator Mitch McConnell — who ironically championed the 2018 Farm Bill that legalized hemp in the first place — centers on public health. Intoxicating hemp products are largely unregulated, sold without age verification in many states, and have been linked to a surge in accidental pediatric exposures. Poison control centers reported a 245 percent increase in calls related to hemp-derived THC products between 2021 and 2025.

What the Farm Bill Does Offer Hemp Farmers

While the intoxicating product ban dominates headlines, the 2026 Farm Bill does offer some relief to the broader hemp industry. The legislation would direct the U.S. Department of Agriculture to reduce or eliminate testing requirements and background checks for industrial hemp producers — those growing hemp for fiber, grain, seed oil, and non-psychoactive CBD products.

The bill recognizes that the overly burdensome compliance framework designed to prevent THC diversion has also punished farmers growing hemp for entirely legitimate industrial purposes. Fiber hemp for textiles, hempcrete for construction, and hemp seed oil for food products operate on razor-thin margins, and regulatory costs have driven many growers out of the market entirely.

For these producers, the Farm Bill represents a genuine step forward. But the segment of the industry that generates the most revenue — psychoactive cannabinoid products — receives no such reprieve.

The Senate Fight Is Next

The House vote is only the first hurdle. The Senate must now pass its own version of the Farm Bill, and negotiations between the chambers could drag into the fall. Hemp industry lobbyists see the Senate as their best opportunity to insert language delaying the November ban or creating a regulatory framework that allows some intoxicating hemp products to survive.

Several proposals are circulating. The Hemp Planting Predictability Act, introduced earlier in 2026, would delay the intoxicating hemp ban by two years to give Congress time to establish proper regulations. A bipartisan group of senators from hemp-producing states has also floated the idea of a tiered system, where products containing up to 5 milligrams of THC per serving could be sold under federal oversight, similar to alcohol regulations.

But the political dynamics are complicated. The licensed cannabis industry, which has spent billions on state compliance, views unregulated hemp products as unfair competition. Many cannabis operators are quietly lobbying to keep the hemp ban in place, arguing that a regulated market cannot coexist with an unregulated one selling functionally identical products at a fraction of the price.

What Businesses Should Do Now

For hemp companies that derive significant revenue from THC products, the next five months demand urgent strategic decisions. Industry consultants are advising businesses to diversify product lines toward non-psychoactive applications, including CBD wellness products that comply with the new THC cap, hemp-derived terpene blends, and CBG or CBN products with minimal THC content.

Companies with strong brand recognition are also exploring pathways into the regulated cannabis market. In states with adult-use licensing, some hemp operators are applying for cultivation and manufacturing licenses, betting that their existing supply chains and customer relationships will transfer.

The most aggressive operators are stockpiling inventory manufactured before the ban takes effect, banking on a legal argument that products produced under the current regulatory framework should be grandfathered in. Legal experts are skeptical of this strategy, warning that the statute's plain language applies to sales and possession, not manufacturing dates.

The Bigger Picture

The hemp ban debate exposes a fundamental tension in American cannabis policy. The federal government has now placed state-licensed medical cannabis in Schedule III while simultaneously moving to ban hemp-derived THC products that millions of consumers use daily. The result is a patchwork where a cancer patient in Georgia can legally obtain cannabis from a dispensary, but a hemp shop in the same state cannot sell a 10-milligram THC gummy.

Whether the Senate preserves, modifies, or delays the hemp ban will shape the cannabis industry for years to come. For 328,000 workers and thousands of businesses, the countdown to November 12 has become the only calendar that matters.